The amygdaloid formation of the lizard Podarcis hispanica can be divided into three main groups of nuclei on the basis of their input from the main and accessory olfactory bulbs: the vomeronasal amygdala, the olfactory amygdala and the dorsal amygdaloid group, the latter group receiving afferents from neither the main (MOB) or the accessory olfactory bulb (AOB). The vomeronasal amygdala has a centrifugal projection to the AOB, an important commissural connection to the contralateral vomeronasal amygdala, a minor projection to nucleus accumbens, and a bilateral projection to the lateral cortex. The olfactory amygdala displays a bilateral afferents from the MOB, receives a contralateral afferent, and is reciprocally connected with the lateral cortex. Moreover, it receives an important input from the vomeronasal amygdala. The dorsal amygdaloid group receives projections from the other two amygdaloid groups, multimodal inputs from the anterior dorsal ventricular ridge and the dorsal cortex, and a putative cholinergic input from the basal telencephalon. Moreover, it is the site of origin of a prominent bilateral amygdalo-striatal projection that extends to the bed nucleus of the stria terminalis and the so-called amygdalo-striatal transition area, through which it may control both visceral and motor activities. The main extratelencephalic output of the amygdala courses through the stria terminalis and terminates in the ventromedial hypothalamic nucleus. The extratelencephalic afferents of the amygdala arise from several hypothalamic and anterior thalamic nuclei, from the mesencephalic and rhombencephalic aminergic cell groups, and from the rhombencephalic parabrachial nucleus.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.